QVT Financial

QVT Financial

Xconomy

SMA Day: AveXis Gene Therapy Creeps Forward as Biogen Drug’s Sales Slow

Health Science
Bloomberg , Xconomy

Novartis to Buy AveXis in $8.7 Billion Gene-Therapy Deal

Health
$30,000,000 Post-IPO debt
businesswire , PE HUB

Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital

$12,000,000
texastechpulse

Dell Buys Exanet

$10,000,000 Venture capital (Series C)
VentureWire , FinSMEs

Gene Therapy Company AveXis Closes $10M Series C

$48,500,000 Venture capital (Series B)
Added by
via PE Hub

Concert Pharma Raises $48.5 Million